David Garcia takes a personalized, clinical approach to weight loss, targeting hormonal, metabolic, and lifestyle factors that often go overlooked
That number dropped from 16 in October 2025 after California, New Hampshire, Pennsylvania, and South Carolina eliminated obesity GLP-1 coverage largely due to state budget constraints
Evidence and Guidance Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
Our team provides clear pricing before your session.
The Trainer Games Complete Collection brings every episode, workout, and behind-the-scenes moment together inside the iFIT fitness app, so you can train, watch, and stay inspired alongside elite trainers from start to finish